← Back to Search

Biopsy Device

Evaluation of the Goldstein SonoBiopsy™ Catheter for Diagnosing Endometrial Pathology

N/A
Waitlist Available
Led By Ricardo Mastellari, MD
Research Sponsored by Cook Group Incorporated
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group

Summary

To assess the adequacy of an endometrial biopsy sample obtained using sonohysterography.

Eligible Conditions
  • Uterine Cancer
  • Polycystic Ovary Syndrome
  • Endometrial Cancer
  • Heavy Menstrual Bleeding

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: SonoBiopsy CatheterExperimental Treatment1 Intervention
Group II: Endometrial biopsy catheterActive Control1 Intervention

Find a Location

Who is running the clinical trial?

Cook Group IncorporatedLead Sponsor
91 Previous Clinical Trials
15,510 Total Patients Enrolled
Ricardo Mastellari, MDPrincipal InvestigatorHospital Punta Pacifica
~0 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top